2317 |
Lessons from European Registries |
Alain G. Cribier |
May. 13. 13 |
2316 |
Early Insights on Cost-effectiveness |
David Joel Cohen |
May. 13. 13 |
2315 |
Technology and Procedural Changes |
Eberhard Grube |
May. 13. 13 |
2314 |
Can We Prevent Conduction Disturbances? |
Corrado Tamburino |
May. 13. 13 |
2313 |
Paravalvular Regurgitation: Incidence, Prevention and Treatment |
Raj Makkar |
May. 13. 13 |
2312 |
Meta-analysis Results Using VARC Definitions |
Phillippe Genereux |
May. 13. 13 |
2311 |
Updates of New TAVI Indications: Valve-in-valve, Bicuspid, Combined CAD... |
Thierry Lefevre |
May. 13. 13 |
2310 |
When to Choose TAVI or Surgical AVR? |
Imad Sheiban |
May. 13. 13 |
2309 |
Pathology of Transcatheter Aortic Valve Implantation |
Renu Virmani |
May. 13. 13 |
2308 |
Aspirin on Top of P2Y12 Inhibitors: Little Benefit, Possible Harm |
Cheol Whan Lee |
May. 13. 13 |